GLP-1 telehealth operations in Florida
Florida is the third-largest compounded GLP-1 market with a uniquely aggressive Department of Health stance on telehealth-only weight-loss programs. The Florida Medical Board and Board of Pharmacy coordinate enforcement against non-compliant programs.
Book a free roadmap callThe Florida market
Florida is the third-largest compounded GLP-1 market with a uniquely aggressive Department of Health stance on telehealth-only weight-loss programs. The Florida Medical Board and Board of Pharmacy coordinate enforcement against non-compliant programs.
Operating rules in Florida
Corporate Practice of Medicine posture: Moderate. Good faith exam format: Synchronous telehealth is required for initial prescribing. Florida's Telehealth Act (§456.47) requires a documented practitioner-patient relationship before prescribing any medication via telehealth. In-person follow-up: No mandatory in-person follow-up for compounded GLP-1, but Florida expects documented clinical evaluation at appropriate intervals and adverse event reporting. Pharmacy licensure: Florida Board of Pharmacy requires nonresident pharmacy permits for any pharmacy shipping prescriptions to Florida patients, including 503A compounding pharmacies. Florida has been particularly active in auditing compounding pharmacies serving telehealth weight-loss programs. Nurse practitioner authority: Autonomous practice ARNPs (per HB 607, effective 2020) have independent prescriptive authority for primary care including GLP-1, but compounded medications and complex protocols typically still require physician medical director oversight. Controlled-substance scheduling: Compounded semaglutide is non-scheduled. Florida has specific PDMP (E-FORCSE) reporting requirements for Schedule II-V controlled substances that may pair with weight-loss protocols.
Statutes and rules cited
Fla. Stat. §456.47 — Florida Telehealth Practice Act: Establishes the standard of care for telehealth practice in Florida, including requirements for establishing a practitioner-patient relationship via telehealth before prescribing. Fla. Stat. §458.331 — Grounds for disciplinary action — medicine: Florida Medical Practice Act provisions defining disciplinary grounds, including prescribing without an examination and inadequate medical records — frequently cited in enforcement against non-compliant telehealth weight-loss programs. Fla. Stat. §465.022 — Pharmacy license required for compounding: Florida pharmacy licensure statute, including the nonresident pharmacy permit requirement for out-of-state pharmacies shipping to Florida patients. Fla. Stat. §464.012 — ARNP autonomous practice: Establishes autonomous practice authority for qualifying ARNPs in Florida — relevant to NP-staffed GLP-1 programs operating without physician delegation.